Renalase Potential as a Marker and Therapeutic Target in Chronic Kidney Disease

被引：0
|
作者：
Serban-Feier, Larisa Florina [1 ,2 ]
Cuiban, Elena [1 ,2 ]
Gogosoiu, Elena Bianca [2 ]
Stepan, Elena [1 ]
Radulescu, Daniela [1 ,2 ]
机构：
[1] Carol Davila Univ Med & Pharm, Fac Med, Dept Nephrol, Bucharest 020021, Romania
[2] Sfantul Ioan Clin Emergency Hosp, Dept Nephrol, Bucharest 042122, Romania
来源：
BIOMEDICINES | 2024年 / 12卷 / 08期
关键词：
renalase; hypertension; cardiovascular disease; chronic kidney disease; PERITONEAL-DIALYSIS PATIENTS; INCREASED SERUM RENALASE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; ALL-CAUSE; CATECHOLAMINES; HYPERTENSION; DOPAMINE; NOREPINEPHRINE;
D O I：
10.3390/biomedicines12081715
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Hypertension and cardiovascular disease are prominent features of chronic kidney disease, and they are associated with premature mortality and progression toward end-stage kidney disease. Renalase, an enzyme secreted predominantly by the kidney and identified in 2005, seems to be one of the missing pieces in the puzzle of heart and kidney interaction in chronic kidney disease by lowering blood pressure and reducing the overactivity of sympathetic tone. This review aims to summarize evidence from clinical studies performed on subjects with CKD in order to explore the value of renalase as a marker and/or a therapeutic target in this disease.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] DKK3 as a diagnostic marker and potential therapeutic target for sarcopenia in chronic obstructive pulmonary disease
    Wang, Zilin
    Deng, Mingming
    Xu, Weidong
    Li, Chang
    Zheng, Ziwen
    Li, Jiaye
    Liao, Liwei
    Zhang, Qin
    Bian, Yiding
    Li, Ruixia
    Miao, Jinrui
    Wang, Kai
    Yin, Yan
    Li, Yanxia
    Zhou, Xiaoming
    Hou, Gang
    REDOX BIOLOGY, 2024, 78
  • [22] Renalase Gene Polymorphism and Epinephrine Level in Chronic Kidney Disease
    Noha A. Rezk
    Haidy E. Zidan
    Yasser A. Elnaggar
    Adel Ghorab
    Applied Biochemistry and Biotechnology, 2015, 175 : 2309 - 2317
  • [23] Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension
    Shibata, Shigeru
    Ishizawa, Kenichi
    Uchida, Shunya
    HYPERTENSION RESEARCH, 2017, 40 (03) : 221 - 225
  • [24] Adaptor protein is a new therapeutic target in chronic kidney disease
    Isaka, Yoshitaka
    KIDNEY INTERNATIONAL, 2017, 92 (06) : 1312 - 1314
  • [25] Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension
    Shigeru Shibata
    Kenichi Ishizawa
    Shunya Uchida
    Hypertension Research, 2017, 40 : 221 - 225
  • [26] Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
    Kim, Yon Su
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (02) : 49 - 51
  • [27] Renalase Gene Polymorphism and Epinephrine Level in Chronic Kidney Disease
    Rezk, Noha A.
    Zidan, Haidy E.
    Elnaggar, Yasser A.
    Ghorab, Adel
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2015, 175 (04) : 2309 - 2317
  • [28] Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease
    Ma, Jingyuan
    Yiu, Wai Han
    Tang, Sydney C. W.
    DIABETIC MEDICINE, 2025, 42 (02)
  • [29] MG53: A potential therapeutic target for kidney disease
    Ke, Ben
    Shen, Wen
    Song, Jianling
    Fang, Xiangdong
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [30] Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
    Cavalcanti Neto, Marinaldo Pacifico
    Aquino, Jailane de Souza
    Romao da Silva, Larissa de Fatima
    Silva, Ruanniere de Oliveira
    de Lima Guimaraes, Keyth Sulamitta
    de Oliveira, Yohanna
    de Souza, Evandro Leite
    Magnani, Marciane
    Vidal, Hubert
    de Brito Alves, Jose Luiz
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 152 - 163
12345